Experts Report Progress in Developing New Tool to Better Track MS Progression

Substantial progress was reviewed at the third annual workshop of the National MS Society-supported MS Outcome Assessments Consortium in Washington, DC in late March. The MSOAC is a global effort aimed at developing a new tool that will address the critical need for a more sensitive way to detect the benefit of potential treatments that slow or reverse progressive disability in people with MS. Participants included representatives from academic institutions, pharmaceutical companies, the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the National Institutes of…

Favicon of da :

Prosegui la lettura...
Traduci l'articolo...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati